Weinrauch LA, et al. – Hypothesthesis stating that among stable kidney transplant recipients, there might be differences between subgroups with and without diabetes with respect to prevalence of prior cardiovascular events and post–transplant antihypertensive and immunosuppressive therapy, has been tested. A greater prevalence of prior cardiovascular events is observed in recipients with diabetes. These patients are more likely to have required multiple medications to control hypertension and are more likely to have received tacrolimus as opposed to cyclosporine than the non–diabetic transplant recipients (all p<0.001). These outcomes call for further exploration of the effect of differences in treatment of non–diabetic vs diabetic cohorts after stable renal transplantation upon outcomes, it can provide additional information that might lead to improved care.